Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
ROLE SUMMARY
As a key member of the Specialty Care Leadership team, the US Rhu/GI TA Lead will be responsible for overseeing Pfizer’s Rhu/GI portfolio (Velsipity and Xeljanz). The US Rhu/GI TA Lead will set the portfolio strategy, maximize performance and patient impact and serve as a leader for the Rhu/GI brands and portfolio functions (ie brand leads, strategy, access integration, TLEL).
RESPONSIBILITIES
• Serve as the end-to-end lead, developing a portfolio level strategy for the Rhu/GI franchise including brand marketing, access strategy, patient support and sales approach
• Deep ownership and understanding of all components of brand and GTN, ultimately accountable for performance and delivery across 2 brands
• Lead and partner across the organization to driving expedited growth for Velsipity, while simultaneously delivering on the Xeljanz LOE plan to optimize return for the organization
• Accountable for the P&L of the Rhu/GI franchise assessing key metrics on an ongoing basis
• Partner with cross functional leads including sales, customer engagement, medical, legal and access to set priorities and identify growth or optimization.
• Identify opportunities to challenge the status quo to grow the assets in the portfolio
• Partner as appropriate with key organizations to establish Pfizer as a leader in the space
• Responsible for the annual operating plan including revenue and expense recommendations
• As a leader of leaders, oversee an organization of ~15 colleagues and ~7 direct reports demonstrating a collaborative and people first mindset, advocating for the growth of your team members
• Partner with Global Commercial Strategy, R&D and business development to evaluate future growth opportunities for the TA
BASIC QUALIFICATIONS
• Bachelor’s degree required; MBA preferred
• 12+ years pharmaceutical experience, to include US market experience
• Demonstrated strategic acumen and bold move thinking
• Proven ability manage complex markets and projects
• Strong people leader with demonstrated ability to lead through change
• Demonstrated ability to challenge the status quo
• Experience in leading and motivating cross functional teams with direct or indirect experience
• Mastery of the P&L and strong financial acumen
• Strong executive presence and experience with senior level executives
• Ability to problem-solve and make decisions in fast-paced environment
PREFERRED QUALIFICATIONS:
• Prior team leadership required; experienced leader of leader strongly preferred
• Deep experience in the US market and understanding of US payer and rebating dynamics required
• I&I experience preferred, but not required
NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS
Domestic travel expected for POAs, congresses, and internal and external meetings
LAST DAY TO APPLY: 11/16/2026
The annual base salary for this position ranges from $254,100.00 to $423,500.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 25.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The Unit
Apply on employer site ↗